{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:31:31Z","timestamp":1791498691505,"version":"4.3.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Community-acquired pneumonia (CAP) remains a leading cause of infectious mortality worldwide. The increasing prevalence of multidrug-resistant (MDR) pathogens challenges the established empirical antibiotic therapy schemes. This study aimed to derive and validate a clinical score (RESPIRE) to identify CAP-MDR patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an observational study in a setting of medium-high multidrug-resistant (MDR) endemicity. The primary outcome was the derivation of a clinical score predicting MDR-CAP. A retrospective derivation cohort (January 2022\u2013December 2023) including adult patients hospitalized with microbiologically confirmed CAP by culture on respiratory samples was used for score derivation. A prospective cohort (January 2024\u2013December 2025) including adult patients with the same clinical features was used for score validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The derivation cohort included 275 patients (mean age 68.3 years), with an MDR prevalence of 30.1% (n = 83). The RESPIRE score assigns 1.5 points for recent hospitalization and prior antibiotic use, and 1 point each for enteral feeding, poor functional status, and residence in long-term care facilities (maximum 6 points). A cutoff \u2265 2 showed optimal performance in predicting CAP-MDR (AUROC 0.85; 95% CI 0.80\u20130.91), outperforming other scores except DRIP. Validation in 141 patients (39% MDR) confirmed an AUROC of 0.88 (95% CI 0.74\u20130.89) showing better performance compared to other diagnostic models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The RESPIRE score outperformed HCAP criteria and other clinical scores in predicting CAP-MDR. Its implementation in protocols could support antimicrobial stewardship for empiric treatment of cases of CAP presenting at the Emergency Department. A multicenter validation is warranted to confirm the performance of the RESPIRE score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NCT07425561<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag319","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:35:17Z","timestamp":1779190517000},"source":"Crossref","is-referenced-by-count":1,"title":["RESPIRE Score: Derivation and Validation of a New Risk Score for Prediction of Community-acquired Pneumonia Caused by Resistant Pathogens"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1849-8372","authenticated-orcid":false,"given":"Lorenzo","family":"Pelagatti","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"Emergency Department, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"De Marco","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bosco","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Catalucci","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gilardoni","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mangani","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"Microbiology and Virology Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-7118","authenticated-orcid":false,"given":"Michele","family":"Spinicci","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"Infectious and Tropical Diseases Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-1523","authenticated-orcid":false,"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"Infectious and Tropical Diseases Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9386-0434","authenticated-orcid":false,"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"Microbiology and Virology Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-9148","authenticated-orcid":false,"given":"Peiman","family":"Nazerian","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"Emergency Department, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-5715","authenticated-orcid":false,"given":"Simone","family":"Vanni","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence ,","place":["Italy"]},{"name":"High Dependency Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2026060214262599200_ofag319-B1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"Aliberti","year":"2021","journal-title":"Lancet"},{"key":"2026060214262599200_ofag319-B2","doi-asserted-by":"crossref","first-page":"11038","DOI":"10.3390\/ijms241311038","article-title":"The global burden of community-acquired pneumonia in adults, encompassing invasive pneumococcal disease and the prevalence of its associated cardiovascular events, with a focus on pneumolysin and macrolide antibiotics in pathogenesis and therapy","volume":"24","author":"Anderson","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026060214262599200_ofag319-B3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Lower Respiratory Infections Collaborators","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026060214262599200_ofag319-B4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.08-1357","article-title":"Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital","volume":"135","author":"Shindo","year":"2009","journal-title":"Chest"},{"key":"2026060214262599200_ofag319-B5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1378\/chest.08-0842","article-title":"Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience","volume":"134","author":"Zilberberg","year":"2008","journal-title":"Chest"},{"key":"2026060214262599200_ofag319-B6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060214262599200_ofag319-B7","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44 Suppl 2","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026060214262599200_ofag319-B8","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060214262599200_ofag319-B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/mdr.1995.1.149","article-title":"Pneumonia: the impact of antibiotic resistance on its management","volume":"1","author":"Finch","year":"1995","journal-title":"Microb Drug Resist"},{"key":"2026060214262599200_ofag319-B10","doi-asserted-by":"crossref","first-page":"91314","DOI":"10.5492\/wjccm.v13.i2.91314","article-title":"Community-acquired pneumonia: the importance of the early detection of drug-resistant organisms","volume":"13","author":"Doppalapudi","year":"2024","journal-title":"World J Crit Care Med"},{"key":"2026060214262599200_ofag319-B11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026060214262599200_ofag319-B12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10096-025-05376-2","article-title":"Rapid testing with molecular syndromic panels of patients presenting at the emergency department with pneumonia at risk for multidrug-resistant pathogens","volume":"45","author":"Pelagatti","year":"2026","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026060214262599200_ofag319-B13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/cit734","article-title":"Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis","volume":"58","author":"Chalmers","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026060214262599200_ofag319-B14","doi-asserted-by":"crossref","first-page":"e0217908","DOI":"10.1371\/journal.pone.0217908","article-title":"Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta lactams in the intensive care unit","volume":"14","author":"Kang","year":"2019","journal-title":"PLoS One"},{"key":"2026060214262599200_ofag319-B15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","article-title":"Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systematic review and meta-analysis","volume":"46","author":"Luther","year":"2018","journal-title":"Crit Care Med"},{"key":"2026060214262599200_ofag319-B16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jac\/dkq038","article-title":"Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic","volume":"65","author":"Chalmers","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2026060214262599200_ofag319-B17","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"key":"2026060214262599200_ofag319-B18","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.168.20.2205","article-title":"Prediction of infection due to antibiotic resistant bacteria by select risk factors for health care-associated pneumonia","volume":"168","author":"Shorr","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026060214262599200_ofag319-B19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.09-2434","article-title":"Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?","volume":"137","author":"Schreiber","year":"2010","journal-title":"Chest"},{"key":"2026060214262599200_ofag319-B20","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score","volume":"60","author":"Webb","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060214262599200_ofag319-B21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5588\/ijtld.12.0723","article-title":"Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients","volume":"17","author":"Park","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026060214262599200_ofag319-B22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060214262599200_ofag319-B23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/thoraxjnl-2013-203384","article-title":"Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective","volume":"68","author":"Aliberti","year":"2013","journal-title":"Thorax"},{"key":"2026060214262599200_ofag319-B24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1513\/AnnalsATS.202005-558OC","article-title":"Validation of a prediction score for drug-resistant microorganisms in community-acquired pneumonia","volume":"18","author":"Ceccato","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026060214262599200_ofag319-B25","volume-title":"L\u2019antibiotico-resistenza e l\u2019uso di antibiotici in Toscana. Rapporto 2023","author":"Agenzia Regionale di Sanit\u00e0 della Toscana (ARS Toscana)","year":"2024"},{"key":"2026060214262599200_ofag319-B26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcrc.2019.06.026","article-title":"Safety of antimicrobial de-escalation for culture-negative severe pneumonia","volume":"54","author":"Byoung Soo","year":"2019","journal-title":"J Crit Care"},{"key":"2026060214262599200_ofag319-B27","first-page":"6","article-title":"Defining community-acquired pneumonia as a public health threat: arguments in favor from Spanish investigators","volume":"8","author":"Cill\u00f3niz","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"2026060214262599200_ofag319-B28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/cir813","article-title":"Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department","volume":"54","author":"Shorr","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026060214262599200_ofag319-B29","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1378\/chest.06-1995","article-title":"Treatment failure in community-acquired pneumonia","volume":"132","author":"Menendez","year":"2007","journal-title":"Chest"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag319\/68352491\/ofag319.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag319\/68352491\/ofag319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag319\/68352491\/ofag319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:26:36Z","timestamp":1780424796000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag319\/8688851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag319","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,21]]},"article-number":"ofag319"}}